How Sigmoidoscopy Differentiates CMV Infection from Ulcerative Colitis
Sigmoidoscopy differentiates CMV infection from UC primarily through obtaining mucosal biopsies for histopathological examination, where CMV is identified by detecting specific viral inclusions using immunohistochemistry (IHC), while UC shows characteristic chronic architectural changes with diffuse inflammation. 1, 2
The Diagnostic Approach
Endoscopic Evaluation
Flexible sigmoidoscopy with mucosal biopsy is the recommended initial investigation in acute severe colitis to differentiate UC from other causes including CMV infection. 1 This approach is safer than full colonoscopy in the acute setting, as colonoscopy may be potentially harmful and should generally be avoided. 1
The key is that sigmoidoscopy alone cannot definitively distinguish CMV from UC based on visual appearance—the differentiation relies on obtaining adequate tissue samples for microscopic analysis.
Histopathological Differentiation
The distinction between CMV colitis and UC is made through specific microscopic features:
For CMV Detection:
- H&E staining reveals enlarged cytomegalic cells with large eosinophilic nuclear inclusions surrounded by a clear halo, plus smaller cytoplasmic inclusions 2
- However, H&E has low sensitivity (10-87%) despite high specificity (92-100%) 2
- Immunohistochemistry (IHC) is superior, improving sensitivity to 78-93% by detecting CMV early antigen using monoclonal antibodies 2
- Quantitative tissue PCR can detect viral DNA, though the significance without histologic signs remains unclear 2
For UC Diagnosis:
- Basal plasmacytosis (earliest and most predictive feature)
- Diffuse crypt architectural distortion and atrophy
- Villous surface irregularity
- Mucin depletion
- Continuous pattern of inflammation 3, 4
Critical Biopsy Strategy
Biopsy location and number are crucial for CMV detection. 5 The evidence shows:
- For UC patients: Obtain at least 11 biopsies from the left colon (primarily sigmoid) to achieve 80% probability of detecting CMV 5
- For Crohn's disease: Require 16 biopsies including right colon, as many CD patients have CMV detectable only in right-colon biopsies 5
- Target areas with endoscopic and histologic inflammation, particularly the base and edges of ulcers where CMV density is highest 6
Clinical Context Matters
CMV reactivation should be suspected in established IBD patients with:
- Steroid-refractory disease (25-30% CMV positivity vs. 0-9.5% in steroid-responding patients) 2
- Severe colitis requiring immunosuppressive therapy 1
- Acute flares despite appropriate treatment 6
The guidelines emphasize that in established IBD patients, co-existent infections including CMV account for a significant proportion of flares, making sigmoidoscopy with biopsy a useful adjunct to indicate superadded infections. 1
Important Caveats
CMV can coexist with UC rather than being mutually exclusive. The presence of CMV doesn't rule out underlying UC—in fact, CMV reactivation occurs preferentially in patients with active UC, particularly those on immunosuppression. 2, 6 This creates a diagnostic challenge: you're not choosing between CMV or UC, but determining if CMV is complicating existing UC.
Pseudomembranes are NOT reliable for CMV diagnosis in IBD patients. While CMV can demonstrate pseudomembranes (similar to C. difficile), these may be absent in IBD patients with CMV infection. 1
Avoid bowel purgatives (especially fleet enemas and oral sodium phosphate preparations) in acute colitis, as they may be harmful. 1, 7
The diagnostic algorithm is straightforward: perform flexible sigmoidoscopy, obtain adequate biopsies (minimum 11 in UC), and send for both routine histology and IHC for CMV. The combination of architectural features (favoring UC) and viral inclusions on IHC (confirming CMV) provides the definitive differentiation.